Results 151 to 160 of about 1,764,849 (239)
Active Breaks in Primary and Secondary School Children and Adolescents: The Point of View of Teachers. [PDF]
Persiani M +8 more
europepmc +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Bowel Preparation for Colonoscopy: The Patient Point of View.
Tontini G +5 more
europepmc +1 more source
Truth-Telling to Palliative Care Patients from the Relatives' Point of View: A Türkiye Sample. [PDF]
Kıraç Utku İ, Şengür E.
europepmc +1 more source
MITF maintains genome stability in nonmelanocyte lineages
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
Will artificial intelligence improve residents' quality of life without compromising healthcare quality? A pediatric point-of-view. [PDF]
Corsello A +3 more
europepmc +1 more source
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Munchausen Syndrome: Another Point of View
Tzee-Chung Wu
doaj +1 more source
Hypersensitivity Reactions to Gadolinium-Based Contrast Agents: Update From an Allergist's Point of View. [PDF]
Losa F +14 more
europepmc +1 more source

